tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

Compare
275 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$9.53
$478.42M
-37.51%
5 Buy
0 Hold
0 Sell
Strong Buy
Ardelyx
$5.72
$1.52B
-32.71%
3 Buy
2 Hold
0 Sell
Moderate Buy
Amphastar Pharmaceuticals
$31.30
$1.48B
10.38
-38.93%
2 Buy
2 Hold
0 Sell
Moderate Buy
Rocket Pharmaceuticals
$10.87
$1.15B
-61.91%
6 Buy
0 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$19.69
$1.41B
-0.15%
4 Buy
0 Hold
0 Sell
Strong Buy
Kezar Life Sciences
$6.40
$43.07M
-24.71%
0 Buy
2 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MLYS
Mineralys Therapeutics, Inc.
9.53
-6.13
-39.14%
ARDX
Ardelyx
5.72
-3.10
-35.15%
AMPH
Amphastar Pharmaceuticals
31.30
-20.61
-39.70%
RCKT
Rocket Pharmaceuticals
10.87
-18.13
-62.52%
KNSA
Kiniksa Pharmaceuticals
19.69
-0.03
-0.15%
KZR
Kezar Life Sciences
6.40
-2.10
-24.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis